Shots: Lurbinectedin (PM1183) a compound under clinical investigation an inhibitor of RNA polymerase II, essential for transcription process that is over-activated in tumors with transcription addiction The designation may provide […]readmore
Biosimilars
Pharma
Celltrion’s Herzuma (Herceptin biosimilar) Receives Marketing Approval in Australia
Shots: Herzuma is first biosimilar approved in Australia for the treatment of early breast cancer, locally advanced or metastatic or advance gastric cancer Including Herzuma Celltrion has three biosimilar for […]readmore
Shots: Mundipharma has gained exclusive distribution rights from Janssen for Europe and Switzerland excluding Spain The drug is recommended for Type 2 Diabetes Mellitus (T2DB) patients with adverse CV disease […]readmore
Shots: Elanco files a registration with U.S. SEC for potential IPO, expected to end by 201 Offering an ownership of <20% shares of Elanco for Lilly The no. of […]readmore
Shots: First and only therapy approved for LD patients with confirmed or acquired in adults and children ≥2yrs; partial or acquired LD in adults or children ≥12yrs in Europe after […]readmore
Shots: Agreement involves the two oral pan-Akt kinase inhibitors afuresertib (ASB183) and uprosertib (UPB795) with >10 clinical Ph1/2 tested for cancer Accordingly, Novartis will acquire equity stake in Laenka adding […]readmore
Shots: The intense market competition leads Novo to focus direct-to-consumer campaign for Ozempic, a once weekly Injectable Type 2 diabetes First sales through total diabetic care fell 5% y-o-y with […]readmore
Shots: The approval is based on two study STICLO France and STICLO Italy assessing Diacomit vs PBO in patients with Dravet Syndrome aged 2 years of age and older taking […]readmore
Shots: EU has approved intake of Xeljanz 10mg BID for 8 weeks followed by 5mg or 10mg for moderate to active UC in adults Xeljanz is now approved in […]readmore
Shots: The agreement includes drug for treatment of acne, fungal skin infections and rosacea, and a range of topical steroids summing up an annual turnover of ≥280 Mn Euros in […]readmore